Doctors across India who encounter Patients with tuberculosis will have to disclose the identity, age, sex, and address of each patient to local health authorities under an order issued this week by the Union health ministry. The health ministry said today that it is essential to have complete information as part of its efforts to ensure that Patients receive proper diagnosis and therapy and to curb the emergence and spread of...

-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...

Human rights commission calls for collective efforts to provide healthcare, compensation to victims and kin The National Human Rights Commission has slammed the Centre and state governments for neglecting workers who are suffering from silicosis—an incurable lung disease caused due to inhalation of silica in dust. The reprimand is in the form of a note that followed the commission's fourth review meeting in New Delhi that concluded on May 4. Over...

When a corporate executive recently landed in the emergency ward of Hiranandani Hospital in Powai with palpitations, doctors first checked his heart. When tests ruled out any cardiac problem, they found an unlikely culprit-too many cups of green tea. "After talking to him, we realized he had had over a dozen cups of green tea within the span of a few hours,'' said cardiologist Ganesh Kumar. Some brands of green tea...

Fighting cancer has just become less expensive for millions of Indian Patients. More than 12 years after he electrified the pharma industry by taking on powerful global giants in his quest to supply cheap anti-AIDS drugs, Cipla promoter YK Hamied is back donning the role of a price warrior. This time, his attention is on anti-cancer drugs. On Thursday, Cipla cut prices of key cancer drugs by nearly 75%, an astounding,...